Literature DB >> 29602852

Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions.

Diana Toledo1,2, Núria Soldevila1,2, Núria Torner1,2,3, María José Pérez-Lozano4, Elena Espejo5, Gemma Navarro6, Mikel Egurrola7, Ángela Domínguez1,2.   

Abstract

OBJECTIVE: Hospital readmission in patients admitted for community-acquired pneumonia (CAP) is frequent in the elderly and patients with multiple comorbidities, resulting in a clinical and economic burden. The aim of this study was to determine factors associated with 30-day readmission in patients with CAP.
DESIGN: A cross-sectional study.
SETTING: The study was conducted in patients admitted to 20 hospitals in seven Spanish regions during two influenza seasons (2013-2014 and 2014-2015). PARTICIPANTS: We included patients aged ≥65 years admitted through the emergency department with a diagnosis compatible with CAP. Patients who died during the initial hospitalisation and those hospitalised more than 30 days were excluded. Finally, 1756 CAP cases were included and of these, 200 (11.39%) were readmitted. MAIN OUTCOME MEASURES: 30-day readmission.
RESULTS: Factors associated with 30-day readmission were living with a person aged <15 years (adjusted OR (aOR) 2.10, 95% CI 1.01 to 4.41), >3 hospital visits during the 90 previous days (aOR 1.53, 95% CI 1.01 to 2.34), chronic respiratory failure (aOR 1.74, 95% CI 1.24 to 2.45), heart failure (aOR 1.69, 95% CI 1.21 to 2.35), chronic liver disease (aOR 2.27, 95% CI 1.20 to 4.31) and discharge to home with home healthcare (aOR 5.61, 95% CI 1.70 to 18.50). No associations were found with pneumococcal or seasonal influenza vaccination in any of the three previous seasons.
CONCLUSIONS: This study shows that 11.39% of patients aged ≥65 years initially hospitalised for CAP were readmitted within 30 days after discharge. Rehospitalisation was associated with preventable and non-preventable factors. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  community acquired pneumonia; elderly; infectious diseases; readmission

Mesh:

Year:  2018        PMID: 29602852      PMCID: PMC5884368          DOI: 10.1136/bmjopen-2017-020243

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


All the information on readmission was obtained from medical records. The study is part of a multicentre study carried out in seven autonomous communities representing 70% of the Spanish population. It was not possible to collect detailed information on the readmission episode.

Introduction

Community-acquired pneumonia (CAP) is a frequent, potentially serious disease in people aged ≥65 years and one of the leading causes of hospitalisation and mortality worldwide in this age group,1–4 in whom recovery from an episode of CAP is predictive of increased mortality in subsequent years.5 The incidence of CAP differs between European countries due to variations in age distribution, the introduction of vaccination programmes and the clinical guidelines used. However, the incidence of cases and hospitalisations increases with age in all countries.6 7 In Spain, CAP is not a reportable disease and therefore the incidence in the population is unknown, although 2013 data also show an increase in hospitalisation (394.04 per 100,000 in the 65–74 years age group and 2584.95 per 100,000 in the >85 years age group).8 In people aged ≥65 years, full recovery after hospitalisation due to CAP is usually slow and the probability of readmission during a period of time after discharge is greater.9 Thirty-day readmission postdischarge is usually used as an indicator of vulnerability.2 10–12 Readmission in patients initially hospitalised due to CAP is relatively frequent (especially in the elderly and patients with multiple comorbidities), and is often associated with a worsening of a baseline disease or the appearance of a new pathology,13 and this results in a significant clinical and economic burden for health systems.2 14 Studies have explored the factors associated with readmission following hospitalisation due to CAP, and have identified factors that improve the prognosis at discharge and are considered preventable, such as influenza and pneumococcal vaccination, the use of hospital care protocols, discharge planning and postdischarge follow-up. Adequate discharge planning, including patient stability and destination, has been associated with reduced readmission.15–17 However, the effect of seasonal influenza and pneumococcal vaccination and the adequacy of hospital care (use of clinical guidelines and antibiotic plans) may be more controversial.18–21 The initial severity of CAP, worsening of comorbidities and some individual patient characteristics have been described as non-preventable factors,15 21–25 and factors such as age, sex, socioeconomic status, education and some comorbidities have been independently associated with a greater likelihood of readmission.25 26 The objective of this study was to determine the risk factors associated with 30-day readmission in people aged ≥65 years initially hospitalised due to CAP.

Materials and methods

Study design

This cross-sectional study was carried out as part of a multicentre study in 20 hospitals from seven Spanish regions (Andalusia, the Basque Country, Castile and Leon, Catalonia, Madrid, Navarre and Valencian Community). Patients aged ≥65 years hospitalised due to CAP in the participating hospitals during the 2013–2014 and 2014–2015 influenza seasons were recruited.

Study population

The Spanish health system assigns each citizen a primary healthcare centre and a referral hospital to be attended. The assignation of the population to each hospital is made according to geography. Consequently, if there is a readmission, it would be in the same hospital. However, in an emergency, the patient may be treated in any hospital. Patients included were aged ≥65 years admitted through the emergency department to any of the participating hospitals for ≥24 hours with a chest X-ray showing pulmonary infiltrate compatible with pneumonia and ≥1 of the following symptoms or signs of acute lower respiratory tract infection: cough, pleural chest pain, dyspnoea, fever >38°C, hypothermia <35°C and abnormal auscultator respiratory sounds unexplained by other causes. Patients who died during the initial hospitalisation and patients hospitalised for more than 30 days were not included. Institutionalised patients, patients with nosocomial pneumonia (onset ≥48 hours after hospital admission), patients whose main residence was not in any of the seven participating regions and those who did not provide signed informed consent were excluded.

Outcomes

The dependent variable was 30-day readmission, defined as ‘hospitalisation for any reason within 30 days of discharge’. Information on readmission was collected by re-review of index hospital medical records up to 30 days after initial discharge. All participating hospitals had a specifically trained team of health professionals who used a structured questionnaire to obtain sociodemographic information and lifestyle factors by patient interview and the review of patient’s medical record to collect immunisation history, risk medical conditions and the CAP hospital care process. Information collected included sociodemographic variables: age, sex, marital status, educational level, cohabitation; lifestyle factors: smoking status (current smoker, ex-smoker, non-smoker) and high alcohol consumption (>40 g/day in men, >20 g/day in women). The Barthel Index27 was used to assess the functional capacity at hospital admission (ranging from 0 — complete dependence to 100 — complete independence). Patients were considered vaccinated against pneumococcal disease if they had received a dose of pneumococcal vaccine in the last 5 years and against seasonal influenza if they had received a dose of the influenza vaccination at least 14 days before symptom onset. Comorbidities considered at high or moderate risk (chronic respiratory failure, history of pneumonia during the last 2 years, solid or haematological neoplasm, diabetes mellitus, renal failure, chronic obstructive pulmonary disease (COPD), heart failure, disabling neurological disease, chronic liver disease and haemoglobinopathy or anaemia) were collected from the patient’s medical record through chart review and were assessed using the Charlson Comorbidity Index,28 which assigns a weight to each comorbid condition (0, no comorbidity; 1, low comorbidity and 2, high comorbidity). Number of primary care nurse visits, number of hospital visits in the last 90 days. Severity of illness quantified in five risk classes using the Pneumonia Severity Index (PSI) at admission,29 length of stay (LOS) <8 and ≥8 days,8 intensive care unit (ICU) admission, mechanical ventilation, adequacy of antibiotic treatment plan according to clinical guidelines (yes/no) and discharge disposition (home without services, home with home healthcare or social health centre) 6 were also colected

Statistical analysis

The Barthel Index, a continuous variable, was dichotomised into 0–89 (moderate-to-high degree of dependency) and ≥90 (little or no dependency). A bivariate analysis was conducted to compare 30-day readmission and no readmission according to sociodemographic variables, lifestyle factors, the Barthel Index, immunisation history, risk medical conditions, prior medical utilisation and hospital care process. Independent variables were checked for collinearity using the variance inflation factor.30 As Spanish regions have varying degrees of autonomy in organising health services, persons living in the same region tend to have similar access to healthcare. Therefore, to estimate the crude OR and adjusted OR (aOR), we used multilevel regression models that considered the outcome variable in people from the same region to obtain accurate statistical estimates of predictors of 30-day readmission.30 Covariates were introduced into the model using a backward stepwise procedure, with a cut-off point of p<0.2. The analysis was performed using the SPSS V.24 statistical package and R V.3.3.0 statistical software.

Results

Overall, 1929 inpatients met all study eligibility criteria for CAP: 93 patients died during the initial hospitalisation and 80 were hospitalised for >30 days. Therefore, 1756 CAP cases were discharged within 30 days after the initial hospitalisation: of these, 200 (11.39%) were readmitted within 30 days after hospital discharge (figure 1).
Figure 1

Flow chart of hospital readmissions. CAP, community-acquired pneumonia.

Flow chart of hospital readmissions. CAP, community-acquired pneumonia. The reasons for 30-day readmission were unrelated to pneumonia in 49.5% (99 cases), pneumonia-related in 44.5% (89 cases) and unknown diagnosis in 6% (12 cases). The descriptive analysis and unadjusted associations of factors related to 30-day readmission are shown in table 1. No differences were observed according to lifestyle factors and immunisation history.
Table 1

Distribution of 30-day readmission cases according to patient characteristics

Readmission n=200No readmission n=1556Crude OR (95%CI)P values
Sociodemographic
Age median (range)80 (65–101)78 (64–100)1.02 (0.99–1.04)0.07
Age group
  65–74 years56 (28.0%)501 (32.2%)1
  75–84 years98 (49.0%)729 (46.9%)1.20 (0.85–1.70)0.31
 >84 years46 (23.0%)326 (20.5%)1.26 (0.83–1.91)0.27
Sex
  Female64 (32.0%)622 (40.0%)1
  Male136 (68.0%)934 (60.0%)1.44 (1.05–1.97)0.02
Educational level
  No/primary education153 (78.1%)1118 (72.4%)1
  Secondary or higher43 (21.9%)427 (27.6%)0.75 (0.51–1.10)0.14
Marital status
  Married/cohabiting116 (58.0%)912 (58.6%)1
  Single21 (10.5%)107 (6.9%)1.56 (0.94–2.59)0.09
  Widowed/divorced63 (31.5%)536 (34.4%)0.93 (0.67–1.29)0.66
Cohabitation
 Lives alone31 (15.5%)289 (18.6%)1
 Lives with cohabitant aged >15 years155 (77.5%)1203 (77.4%)1.20 (0.80–1.80)0.39
 Lives with cohabitant aged <15 years14 (7.0%)63 (4.1%)2.03 (1.02–4.04)0.04
Lifestyle factors
Smoking status
  Non-smoker79 (39.5%)693 (44.5%)1
  Smoker16 (8.0%)138 (8.9%)1.04 (0.59–1.83)0.90
  Ex-smoker105 (52.5%)725 (46.6%)1.28 (0.94–1.75)0.11
High alcohol consumption
  No197 (98.5%)1524 (97.9%)1
  Yes3 (1.5%)32 (2.1%)1.38 (0.42–4.54)0.60
Prior utilisation of resources
No of nurse visits in last 90 days
  0–2147 (73.5%)1182 (76.4%)1
 ≥353 (26.5%)365 (23.6%)1.17 (0.82–1.65)0.39
No of hospital visits in last 90 days
  0–2164 (82.8%)1355 (87.6%)1
 ≥334 (17.2%)192 (12.4%)1.53 (1.02–2.31)0.04
Barthel Index
 Little or no dependency >90108 (54.0%)990 (63.6%)1
 Moderate-to-high dependency ≤9092 (46.0%)566 (36.4%)1.47 (1.08–2.01)0.01
Immunisations
Influenza vaccination in any of the three previous seasons
  No54 (27.0%)464 (29.8%)1
  Yes146 (73.0%)1092 (70.2%)1.16 (0.83–1.61)0.39
Pneumococcal vaccination in five previous years
  No161 (80.5%)1281 (82.3%)1
  Yes39 (19.5%)275 (17.7%)1.11 (0.76–1.62)0.58
Risk medical conditions
Chronic respiratory failure
  No136 (68.0%)1269 (81.6%)1
  Yes64 (32.0%)287 (18.4%)2.08 (1.50–2.88)<0.001
Pneumonia during the last 2 years
  No146 (73.0%)1267 (81.4%)1
  Yes54 (27.0%)289 (18.6%)1.65 (1.18–2.32)0.004
Any malignancy
  No161 (80.5%)1271 (81.7%)1
  Yes39 (19.5%)285 (18.3%)1.08 (0.74–1.58)0.67
Diabetes
  No139 (69.5%)1023 (65.7%)1
  Yes61 (30.5%)533 (34.3%)0.83 (0.60–1.14)0.26
Renal failure
  No151 (75.5%)1263 (81.2%)1
 Yes49 (24.5%)293 (18.8%)1.38 (0.97–1.96)0.07
Chronic obstructive pulmonary disease
  No128 (64.0%)1074 (69.0%)1
  Yes72 (36.0%)482 (31.0%)1.25 (0.92–1.70)0.16
Heart failure
  No128 (64.0%)1168 (75.1%)1
 Yes72 (36.0%)388 (24.9%)1.69 (1.24–2.31)0.001
Chronic liver disease
  No186 (93.0%)1504 (96.7%)1
 Yes14 (7.0%)52 (3.3%)2.13 (1.15–3.94)0.01
Haemoglobinopathy or anaemia
  No160 (80.0%)1324 (85.1%)1
  Yes40 (20.0%)232 (14.9%)1.40 (0.96–2.04)0.08
Disabling neurological disease
  No179 (89.5%)1416 (91.0%)1
 Yes21 (10.5%)140 (9.0%)1.17 (0.72–1.90)0.52
Charlson Index
  No comorbidity (0)18 (9.0%)233 (15.0%)1
  Low comorbidity (1)54 (27.0%)378 (24.3%)1.83 (1.05–3.20)0.03
  High comorbidity (≥2)128 (64.0%)945 (60.7%)1.71 (1.02–2.86)0.04
Hospital care process
Intensive care unit
  No188 (94.5%)1499 (96.9%)1
  Yes11 (5.5%)48 (3.1%)1.93 (0.97–3.81)0.06
Mechanical ventilation
  No157 (78.5%)1317 (84.9%)1
 Yes43 (21.5%)235 (15.1%)1.50 (1.03–2.18)0.03
Pneumonia Severity Index
  I–III69 (34.7%)645 (41.7%)1
  IV–V130 (65.3%)902 (58.3%)1.40 (1.02–1.92)0.04
Length of hospital stay
 <8 days80 (40.0%)766 (49.2%)1
 ≥8 days120 (60.0%)790 (50.8%)1.45 (1.05–2.02)0.02
Antibiotic treatment
  No97 (50.3%)700 (46.6%)1
  Yes96 (49.7%)802 (53.4%)1.07 (0.76–1.50)0.70
Discharge disposition
 Home without services185 (92.5%)1477 (94.9%)1
 Home with home healthcare9 (4.5%)19 (1.2%)5.05 (1.58–16.15)0.01
 Social health centre6 (3.0%)60 (3.9%)1.23 (0.41–2.92)0.63
Distribution of 30-day readmission cases according to patient characteristics Factors independently associated with 30-day readmission in the multilevel analysis (table 2) were living with a person aged <15 years (aOR 2.10, 95% CI 1.01 to 4.41; p=0.04), more than three hospital visits during the 90 previous days (aOR 1.53, 95% CI 1.01 to 2.34; p=0.04) chronic respiratory failure (aOR 1.74, 95% CI 1.24 to 2.45; p=0.001), heart failure (aOR 1.69, 95% CI 1.21 to 2.35; p=0.002), chronic liver disease (aOR 2.27, 95% CI 1.21 to 4.31; p=0.01) and discharge to home with home healthcare (aOR 5.61, 95% CI 1.70 to 18.50; p=0.005).
Table 2

Multilevel regression analysis of factors associated with 30-day readmission

Adjusted OR (95%CI)P values
Age1.02 (0.99–1.04)0.13
Sex—male1.39 (0.99–3.12)0.06
Cohabitation
 Lives alone1
 Lives with cohabitant aged >15 years1.17 (0.71–1.95)0.54
 Lives with cohabitant aged <15 years2.10 (1.01–4.41)0.04
Marital status
 Married/cohabiting1
  Single1.73 (0.96–3.11)0.07
  Widowed/divorced0.94 (0.61–1.44)0.77
 No of hospital visits ≥31.53 (1.01–2.34)0.04
Barthel Index
 Moderate-to-high dependency ≤901.39 (0.99–1.95)0.05
 Pneumonia during the last 2 years1.31 (0.91–1.88)0.14
 Chronic respiratory failure1.74 (1.24–2.45)0.001
 Diabetes0.74 (0.53–1.04)0.08
 Heart failure1.69 (1.21–2.35)0.002
 Chronic liver disease2.27 (1.20–4.31)0.01
 Mechanical ventilation1.33 (0.90–1.97)0.15
Discharge disposition
 Home without services1
 Home with home healthcare5.61 (1.70–18.50)0.005
 Social health centre1.27 (0.53–3.05)0.59
Multilevel regression analysis of factors associated with 30-day readmission A moderate-to-high degree of dependency was tentatively associated with readmission (aOR 1.39, 95% CI 0.99 to 1.95; p=0.05). No associations were observed with age, sex, pneumococcal vaccination or seasonal influenza vaccination in any of the three previous seasons, the PSI or any variable related to the hospital care process.

Discussion

The overall 30-day readmission rate in our study was 11.39%. Although all participating hospitals were referral centres, readmission rates ranged between regions from 2.5% to 14%. This might be due to the differences in the hospital healthcare burden of participating hospitals and in the protocols used. In the Pneumonia Patient Outcomes Research Team cohort study, carried out in the USA and Canada, the readmission rate in adults was 10.1%.31 Readmission rates at 30 days in people aged ≥65 years admitted for CAP vary between 8% and 27%, depending on the population and country studied.11 19 21 25 32 In Spain, national data show 30-day readmissions increased from 11.5% in 2004 to 13.5% in 2013 in adults admitted for CAP.8 Our results show that non-preventable factors, specifically patient characteristics (living with a person aged <15 years, more than three hospital visits during the 90 previous days and some comorbidities) and one preventable factor (discharge disposition) were significantly associated with 30-day readmission. Factors such as cohabitation and the discharge dispostion have been little studied and their identification provides a new perspective on the risk factors involved in 30-day readmission of these patients. Calvillo-King et al in a thorough review of studies on readmission, underlined the importance of considering social factors (sociodemographic, socioeconomic and the social environment) as elements that could influence readmission after an episode of CAP.22 Our study evaluated sociodemographic and socioeconomic factors and the social environment. Although the influence of sex varies between studies and may be closely related to other factors such as age, risk habits and some comorbidities, the association with male sex disappeared in the final model, in contrast to the results found by Neupane et al, and Bohannon and Maljanian.19 33 Patients living with children aged <15 years had a twofold higher probability of readmission than those living alone or with a partner. Although it is known that school children may be a source of infection of the elderly in some infectious diseases, we found no studies that investigated the type of cohabitation in this context, possibly because one factor usually associated with readmission in people aged ≥65 years is living in geriatric residences.11 In Spain, the recommendation of vaccination of persons in contact with high-risk persons, including persons aged ≥65 years with risk factors has been maintained.34 We also found no association with factors identified by other authors, such as the educational level or the history of smoking or alcohol use.25 35 In the studies by Neupane et al in two Canadian cities and Adamuz et al in a tertiary hospital in Barcelona, seasonal influenza and pneumococcal vaccination were included in the adjusted analysis of readmission due to CAP, but no association was found.19 23 We investigated seasonal influenza and pneumococcal vaccination in the previous 5 years but found no association in the crude or adjusted models. In our study, 49.5% of 30-day readmissions were due to causes unrelated to CAP and 91% of readmitted patients presented comorbidities. Patients with chronic liver disease, heart failure and respiratory failure had higher 30-day readmission rates, findings consistent with other studies showing that some cardiovascular and respiratory diseases play an important role in the risk of readmission in patients with CAP,12 23–25 36 and that the reason for readmission generally differs from the initial diagnosis of CAP due, in most cases, to destabilisation of comorbidities10 23–26 37 38. Fine et al, in a cohort study, found that pneumonia often occurs in patients with underlying comorbidities and often results in a worsening of such underlying conditions.31 We found an association with prior hospital utilisation in the 90 days before admission for CAP, but no association with general practitioner and primary care nurse visits. Healthcare in Spain is free, which encourages patients to make multiple visits to primary care centres and/or hospitals, ensuring patient care and follow-up. Adamuz et al and Tang et al found an association between readmission and hospitalisation in the 90 days before admission for CAP.11 23 One preventable factor that influences CAP episodes in people aged ≥65 years is the quality of care received during hospitalisation, while discharge planning and follow-up until recovery influence patient recovery and, therefore, readmission.16 21 23 24 We found, as did Dong et al,16 an association with discharge to home with home healthcare. A possible explanation might be an inadequate evaluation of the patient’s stability at discharge. Various authors have suggested the importance of the discharge dispostion in patients admitted due to other causes such as COPD or some specific interventions.39–41 However, with respect to patients with CAP, only Dong et al and the present study have found an association between the discharge dispostion and readmission. Other variables related to the quality of care were studied to assess these aspects but no association with readmission was found.

Strengths and limitations

The main strength of the study is that all clinical information was obtained from patient medical records and, therefore, was unlikely to be biased. Another strength is the cross-sectional design, as it is part of a multicentre study carried out in seven regions representing 70% of the Spanish population. A limitation is that it was not possible to collect patient characteristics at discharge, and therefore we cannot say whether there was instability at discharge that may have caused the readmission. Therefore, the variable ‘discharge disposition’ was considered as a proxy to define instability.

Conclusions

In conclusion, this study shows that 11.39% of patients aged ≥65 years hospitalised due to CAP are readmitted within 30 days after an episode of CAP and that this was associated with living with a cohabitant aged <15 years, more than three hospital visits during the 90 previous days, chronic respiratory failure, heart failure, chronic liver disease and discharge to home with home healthcare services. Because social factors, in addition to postdischarge and prereadmission clinical information, may influence the prognosis, it is important that these factors continue to be considered in future research.
  37 in total

1.  Chronic Obstructive Pulmonary Disease Is Associated With Short-Term Complications Following Total Hip Arthroplasty.

Authors:  George A Yakubek; Gannon L Curtis; Nipun Sodhi; Mhamad Faour; Alison K Klika; Michael A Mont; Wael K Barsoum; Carlos A Higuera
Journal:  J Arthroplasty       Date:  2018-01-09       Impact factor: 4.757

2.  Association between frailty and 30-day outcomes after discharge from hospital.

Authors:  Sharry Kahlon; Jenelle Pederson; Sumit R Majumdar; Sara Belga; Darren Lau; Miriam Fradette; Debbie Boyko; Jeffrey A Bakal; Curtis Johnston; Raj S Padwal; Finlay A McAlister
Journal:  CMAJ       Date:  2015-05-25       Impact factor: 8.262

3.  The association of discharge destination with 30-day rehospitalization rates among older adults receiving lumbar spinal fusion surgery.

Authors:  Chad Cook; Rogelio A Coronado; Janet Prvu Bettger; James E Graham
Journal:  Musculoskelet Sci Pract       Date:  2018-01-12       Impact factor: 2.520

4.  Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia.

Authors:  Peter K Lindenauer; Sharon-Lise T Normand; Elizabeth E Drye; Zhenqiu Lin; Katherine Goodrich; Mayur M Desai; Dale W Bratzler; Walter J O'Donnell; Mark L Metersky; Harlan M Krumholz
Journal:  J Hosp Med       Date:  2011-01-05       Impact factor: 2.960

5.  Thirty-day rehospitalizations after acute myocardial infarction: a cohort study.

Authors:  Shannon M Dunlay; Susan A Weston; Jill M Killian; Malcolm R Bell; Allan S Jaffe; Véronique L Roger
Journal:  Ann Intern Med       Date:  2012-07-03       Impact factor: 25.391

6.  Indicators of recurrent hospitalization for pneumonia in the elderly.

Authors:  Ali A El Solh; Thomas Brewer; Mifue Okada; Omar Bashir; Michael Gough
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

7.  Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?

Authors:  T J Marrie; E V Haldane; R S Faulkner; H Durant; C Kwan
Journal:  J Am Geriatr Soc       Date:  1985-10       Impact factor: 5.562

8.  Iatrogenic illness on a general medical service at a university hospital.

Authors:  K Steel; P M Gertman; C Crescenzi; J Anderson
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

9.  Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.

Authors:  Harish Jasti; Eric M Mortensen; David Scott Obrosky; Wishwa N Kapoor; Michael J Fine
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

10.  Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.

Authors:  Àngela Domínguez; Núria Soldevila; Diana Toledo; Núria Torner; Luis Force; María José Pérez; Vicente Martín; Lourdes Rodríguez-Rojas; Jenaro Astray; Mikel Egurrola; Francisco Sanz; Jesús Castilla
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

View more
  9 in total

1.  Risk factors for hospital readmissions in pneumonia patients: A systematic review and meta-analysis.

Authors:  Yuan-Yuan Fang; Jian-Chao Ni; Yin Wang; Jian-Hong Yu; Ling-Ling Fu
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

Review 2.  Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age.

Authors:  Frances Susanna Grudzinska; Malcolm Brodlie; Barnaby R Scholefield; Thomas Jackson; Aaron Scott; David R Thickett; Elizabeth Sapey
Journal:  Thorax       Date:  2019-11-15       Impact factor: 9.139

3.  Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia.

Authors:  Biswajit Chakrabarti; Steven Lane; Tom Jenks; Joanne Higgins; Elizabeth Kanwar; Martin Allen; Dan Wotton
Journal:  BMJ Open Respir Res       Date:  2021-03

4.  Combined Neutrophil-to-Lymphocyte Ratio and CURB-65 Score as an Accurate Predictor of Mortality for Community-Acquired Pneumonia in the Elderly.

Authors:  Ding-Yun Feng; Xiao-Ling Zou; Yu-Qi Zhou; Wen-Bin Wu; Hai-Ling Yang; Tian-Tuo Zhang
Journal:  Int J Gen Med       Date:  2021-03-30

5.  Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes.

Authors:  Amy Kang; Richard Beuttler; Emi Minejima
Journal:  Ther Adv Infect Dis       Date:  2022-01-30

6.  Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool.

Authors:  Verena Glöckner; Mathias W Pletz; Gernot Rohde; Jan Rupp; Martin Witzenrath; Grit Barten-Neiner; Martin Kolditz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-02-08       Impact factor: 3.267

7.  Re-Admission of COVID-19 Patients Hospitalized with Omicron Variant-A Retrospective Cohort Study.

Authors:  Irit Ayalon-Dangur; Adi Turjeman; Bar Basharim; Noa Bigman-Peer; Einat Magid; Hefziba Green; Tzippy Shochat; Alon Grossman; Jihad Bishara; Noa Eliakim-Raz
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

8.  Risk factors of 90-day rehospitalization following discharge of pediatric patients hospitalized with mycoplasma Pneumoniae pneumonia.

Authors:  Le Wang; Zhishan Feng; Jinfeng Shuai; Jianhua Liu; Guixia Li
Journal:  BMC Infect Dis       Date:  2019-11-12       Impact factor: 3.090

9.  Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients.

Authors:  Chun-Ta Huang; Chun-Ming Hong; Yi-Ju Tsai; Wang-Huei Sheng; Chong-Jen Yu
Journal:  BMC Gastroenterol       Date:  2020-11-16       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.